XML 28 R17.htm IDEA: XBRL DOCUMENT v3.19.2
Goodwill and Intangible Assets, Net
 3 Months Ended
Jun. 30, 2019
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets, Net
Goodwill and Intangible Assets, Net
Changes in the carrying amount of goodwill were as follows:
(In millions)
U.S. Pharmaceutical and Specialty Solutions
 
European Pharmaceutical Solutions
 
Medical-Surgical Solutions
 
Other
 
Total
Balance, March 31, 2019
$
4,078

 
$
—

 
$
2,451

 
$
2,829

 
$
9,358

Goodwill acquired
—

 
39

 
—

 
—

 
39

Acquisition accounting, transfers and other adjustments
1

 
1

 
7

 
—

 
9

Foreign currency translation adjustments, net
9

 
—

 
—

 
26

 
35

Balance, June 30, 2019
$
4,088

 
$
40

 
$
2,458

 
$
2,855

 
$
9,441


As of June 30, 2019 accumulated goodwill impairment losses were $2,913 million in our European Pharmaceutical Solutions segment and $470 million in Other. As of March 31, 2019 accumulated goodwill impairment losses were $2,943 million in our European Pharmaceutical Solutions segment and $461 million in Other.
Information regarding intangible assets is as follows:
 
June 30, 2019
 
March 31, 2019
(Dollars in millions)
Weighted
Average
Remaining
Amortization
Period
(years)
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Net
Carrying
Amount
Customer relationships
12
 
$
3,831

 
$
(1,871
)
 
$
1,960

 
$
3,818

 
$
(1,801
)
 
$
2,017

Service agreements
11
 
1,022

 
(447
)
 
575

 
1,017

 
(430
)
 
587

Pharmacy licenses
26
 
513

 
(210
)
 
303

 
513

 
(209
)
 
304

Trademarks and trade names
13
 
893

 
(244
)
 
649

 
887

 
(232
)
 
655

Technology
4
 
141

 
(98
)
 
43

 
141

 
(94
)
 
47

Other
5
 
282

 
(212
)
 
70

 
288

 
(209
)
 
79

Total
 
 
$
6,682


$
(3,082
)
 
$
3,600

 
$
6,664

 
$
(2,975
)
 
$
3,689


Amortization expense of intangible assets was $112 million and $122 million for the quarters ended June 30, 2019 and 2018. Estimated amortization expense of these assets is as follows: $298 million, $389 million, $365 million, $277 million and $248 million for the remainder of 2020 and each of the succeeding years through 2024 and $2,023 million thereafter. All intangible assets were subject to amortization as of June 30, 2019 and March 31, 2019.